Pictet & Cie (Europe) Sa Moderna, Inc. Transaction History

Pictet & Cie (Europe) Sa

$4.08 Billion
Q2 2024

A detailed history of Pictet & Cie (Europe) Sa transactions in Moderna, Inc. stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 522,626 shares of MRNA stock, worth $34.4 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares

522,626

Previous 523,626 0.19%

Holding current value

$34.4 Million

Previous $55.8 Million 11.23%

% of portfolio

1.52%

Previous 1.47%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$101.21 - $166.61 $101,210 - $166,610	-1,000 Reduced 0.19%	522,626 $62.1 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $2.04 Million - $3.06 Million	29,338 Added 5.94%	523,626 $52.1 Million
Q3 2023 Nov 02, 2023	BUY	$96.41 - $126.61 $14.5 Million - $19 Million	150,000 Added 43.57%	494,288 $51.1 Million
Q2 2023 Aug 08, 2023	BUY	$118.5 - $160.53 $133,194 - $180,435	1,124 Added 0.33%	344,288 $41.8 Million
Q1 2023 May 01, 2023	BUY	$135.66 - $197.02 $26.9 Million - $39 Million	197,928 Added 136.28%	343,164 $52.7 Million
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $12.2 Million - $21.6 Million	102,947 Added 243.44%	145,236 $0
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $4.43 Million - $7.29 Million	37,546 Added 791.61%	42,289 $5 Billion
Q1 2022 May 04, 2022	SELL	$126.46 - $235.05 $183,872 - $341,762	-1,454 Reduced 23.46%	4,743 $817,000
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $754,916 - $1.23 Million	3,343 Added 117.13%	6,197 $1.57 Million
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $40,163 - $87,689	-181 Reduced 5.96%	2,854 $1.1 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $27,930 - $50,520	215 Added 7.62%	3,035 $713,000
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $307,887 - $524,463	2,820 New	2,820 $369,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Moderna, Inc. Transaction History